Vadim Gauthier-Bernard
3801 University Street
Montreal, QC, Canada
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
NTRK Gene Fusions: A Compendium of Fusion Partners and Tumor Types.
Journal: JCO precision oncology
Published: May 06, 2026
The complexity of finding fit-for-purpose real-world data for oncology patients with rare NTRK gene fusions and a novel solution.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer.
Journal: JCO precision oncology
Published: April 23, 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer.
Journal: ESMO open
Published: April 03, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 03, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 14, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 27, 2025
A plain language summary looking at how well larotrectinib works and how safe it is for people with TRK fusion-positive thyroid cancer.
Journal: Future oncology (London, England)
Published: November 30, 2024
Preliminary Evaluations of [11C]Verubulin: Implications for Microtubule Imaging With PET.
Journal: Frontiers in neuroscience
Published: June 15, 2021
Radiofluorination of oxazole-carboxamides for preclinical PET neuroimaging of GSK-3.
Journal: Journal of fluorine chemistry
Published: April 12, 2021
Efficient radiosynthesis and preclinical evaluation of [18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging.
Journal: Journal of labelled compounds & radiopharmaceuticals
Published: October 08, 2019
Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery.
Journal: Journal of medicinal chemistry
Published: September 20, 2019
Last Updated: 09/26/2026